Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLK - Glucosamine treatment effect on KMH2 malignant lymphocytes
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COL17A1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
OBFC1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
SFR1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
CFAP43 - Glucosamine treatment effect on KMH2 malignant lymphocytes
GSTO1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
SH3PXD2A - Glucosamine treatment effect on KMH2 malignant lymphocytes
GSTO2 - Glucosamine treatment effect on KMH2 malignant lymphocytes
ITPRIP - Glucosamine treatment effect on KMH2 malignant lymphocytes
CFAP58 - Glucosamine treatment effect on KMH2 malignant lymphocytes
NEURL1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
CALHM3 - Glucosamine treatment effect on KMH2 malignant lymphocytes
CALHM1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
CALHM2 - Glucosamine treatment effect on KMH2 malignant lymphocytes
PDCD11 - Glucosamine treatment effect on KMH2 malignant lymphocytes
MIR1307 - Glucosamine treatment effect on KMH2 malignant lymphocytes
USMG5 - Glucosamine treatment effect on KMH2 malignant lymphocytes
SORCS3 - Glucosamine treatment effect on KMH2 malignant lymphocytes
SORCS1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on